Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H28N2O2 |
| Molecular Weight | 304.4271 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(C)=CC(C)=C1NC(=O)CCN2CCCCC2C
InChI
InChIKey=UJCARUGFZOJPMI-UHFFFAOYSA-N
InChI=1S/C18H28N2O2/c1-13-11-14(2)18(16(12-13)22-4)19-17(21)8-10-20-9-6-5-7-15(20)3/h11-12,15H,5-10H2,1-4H3,(H,19,21)
Vadocaine is an anilide derivative with antitussive and local anaesthetic action. Vadocaine is highly distributed to the respiratory tract. In chemical structure vadocaine resembles lidocaine. According to the serum concentrations and pharmacokinetic parameters, no cumulation of vadocaine was observed. The compound had no effect on blood and urinary parameters measured for safety evaluation. Vadocaine is evidently metabolized in the liver and a remarkable part of the drug and its metabolites are excreted into the bile. Accumulation of radioactivity in the kidneys shows that also renal elimination is important.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3395404
Single dose - 300 mg
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C051410
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
SUB00002MIG
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
100000079139
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
C72163
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
5974
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
68912
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
DTXSID40868065
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
72005-58-4
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104555
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY | |||
|
OKA45SU1Q4
Created by
admin on Mon Mar 31 18:20:12 GMT 2025 , Edited by admin on Mon Mar 31 18:20:12 GMT 2025
|
PRIMARY |
ACTIVE MOIETY